CHARLES R. STRUBY, PH.D.

, CPA

Furlong, Pa 18925
C: (305) 924-6800 mrstruby@aol.com

GENERAL MANAGER

Hands-on, mentoring leader with record of success increasing organizations’ revenues, productivity,
product base and bottom line results. In depth understanding of an organization’s inner workings
with accomplished expertise in strategic planning, leadership development, building
multifunctional teams, leading international business teams, investor relations, business
development, new product commercialization, financial managment, program management and
management training

PROFESSIONAL EXPERIENCE

SUCCESSFULLY ACHIEVED FOUR COMPANIES’ EXPANSION OR TURNAROUND

STRATEGIES 2005-2010

IVAX DIAGNOSTICS, INC. (Public, multinational, invitro diagnostics company in need of take
charge individual to position the company for growth or acquisition)
CEO & President (1/2009-9/2010)

1 Identified and led implementation of strategy to expanded product line and geographic presence
2 Increased Company market value 48% in eighteen months
3 Broke down existing silos among three sites, one in Europe, by aligning the organization
functionally
4 Negotiated seven distribution agreements, two in Europe, which expanded Company’s product
platform and reach in the U.S. and Europe 100%
5 Positioned company for growth or acquisition, the latter occurring September 2010 via change of
control

THE MEDICINES COMPANY (Acute-care pharmaceutical company in need of corporate

development strategy and expanded business development function)
Senior Director, Business Development (2006-2008)
1 Created a business development department of five employees responsible for identifying,
evaluating, conducting due diligence and acquiring late-stage development compounds
and/or companies targeting acute care hospital medicines.
2 Designed the corporate business development strategy and related processes that provided a
consistent roadmap for identifying and evaluating opportunities resulting in a quick 'Go/No
Go' decision before committing significant corporate resources to in-depth due diligence.

HARTE-HANKS, INC. (Direct marketing company in need of experienced leader to reverse

operating unit’s declining profits and increase pharmaceutical revenue base) (2005-2006)
General Manager, Kansas City Operations
Reversed declining profit trend by providing overall leadership with full P&L responsibility to a 421
person unit.
1 Aligned functions around key account teams, which broke down functional silos and
assigned clear accountability for focusing on the customer. Results included increased
employee morale, reduced spoilage and lost merchandise, and improved customer
satisfaction as reflected in annual surveys.
2 Managed client relationships which generated new business with three of the top ten
pharmaceutical companies increasing unit revenues 10%.
3 Elevated the unit's operating results from third to first among four locations by increasing net
profits over 300% (from 4% to 17%) over a nine month period.

THE MATTSON-JACK GROUP, INC. (Consultants to the pharmaceutical industry in need of

expanding to Japan)
Vice President, Corporate Development Services (2005)
1 Accomplished ahead of schedule a commitment to expand the company's global reach by
establishing a presence in Japan. This expanded the company's reach outside the U.S.,
providing a new avenue to help U.S. based clients achieve their Japan expansion strategy.
2 Provided strategic consulting to the pharmaceutical and biotechnology industries in key areas
of strategic planning, product development, M&A, forecasting and market research.

SANOFI-AVENTIS PHARMACEUTICALS, INC. 1982 - 2004

Vice President
Senior-level positions of increasing importance across a broad range of functional areas of program
management, alliance management, licensing, new products commercialization and training
1 Created a new products commercialization department of 14 associates responsible for
leading multifunctional teams determining the commercial potential and positioning strategy
of all clinical development compounds, excluding oncology. Compound development
timelines were reduced by 2-3 years, resulting in millions of dollars in savings to the
company. The model became the global template for commercializing new products.
2 Led compound in- and out-licensing due diligence and negotiation teams resulting in four
in-licensing arrangements, two multi-compound development collaborations, one research
collaboration and one divestiture.
3 Led the joint integration team of a multi-compound R&D development partnership resulting
in appointment as General Manager.

Previous Experience:
RYDER SYSTEMS, INC. (global transportation company)
Manager, Financial Reporting and Accounting
HOUSING INVESTMENT CORPORATION (JPMorgan Chase REIT subsidiary)
Controller
KPMG (international accounting and consulting firm)
Senior Accounting Auditor

EDUCATION
Ph.D. Pharmaceutical Sciences, University of Missouri at Kansas City
 M.S. Accounting, Louisiana State University, Baton Rouge, LA
B.S. Business, Kansas State University, Manhattan, KS

CERTIFICATIONS/AWARDS/AFFILIATIONS
Marketing Leadership Award
Certified Public Accountant (inactive)
Temple University, Fox School of Business Advisory Council
Adjunct Professor (accounting, management, international business)
University of Missouri at Kansas City School of Pharmacy Advisory Council